Frequency of Gastroesophageal Reflux Disease in Chronic Obstructive Pulmonary Disease Patients
Abstract
Background: About 20% to 30% of the general population, especially in individuals with old age, suffers from gastroesophageal reflux disease. Association between gastroesophageal reflux disease and chronic obstructive pulmonary disease has been reported in numerous studies. Objective: To find out the frequency of gastroesophageal reflux disease in chronic obstructive pulmonary disease patients Methodology: This cross-sectional study was carried out at the department of Pulmonology, Fatima Jinnah Institute of Chest Diseases and Sheikh Khalifa Bin Zayyed Al Nahyan Medical Complex Quetta from December 2021 to May 2022. The inclusion criteria for our study were all the patients of either gender in age range 18 to 60 years diagnosed with COPD of any severity level. A proforma developed solely for this research was used to record all the data. All the collected data was analyzed by using SPSS version 23. Results: In our study, totally 180 patients were enrolled. There were 120 (66.67%) male participants and 60 (33.33%) female participants in our study. The overall frequency of gastro-esophageal reflux disease in COPD patients was 93 (51.67%). The frequency of gastro-esophageal reflux disease in mild, moderate severe and very severe COPD patients COPD patients was 4 (44.44%), 39 (48.15%), 38 (52.78%) and 12 (66.66%) respectively. Conclusion: Our study concludes that the frequency of gastroesophageal reflux disease is high in chronic obstructive pulmonary disease patients. Based on…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 180 participants or records.
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.